期刊文献+

改善心室重构的药物和方法研究进展 被引量:2

Advancement of agents and methods for the improvement of myocardial remodeling
暂未订购
导出
摘要 心室重构进一步导致心力衰竭,引起心原性死亡。近年来,许多心力衰竭、心原性猝死的研究致力于心室重构的改善和逆转。有的获得了肯定的疗效,有的尚在进一步探讨中。本文对近年来改善心室重构的药物和方法研究进行归纳和总结。 Myocardial remodeling gradually leads to cardiac failure and arouses cardiac sudden death. In recent years, many studies of the cardiac failure and sudden death take up with the amelioration and reverse of themyocardial remodeling. Some of these new attempts acquired positive curative effect. Some were still in discussion. This article reviewed these medicaments and methods and slakes some conclusions and summarizations.
出处 《中国医药导报》 CAS 2009年第26期5-5,8,共2页 China Medical Herald
关键词 心室重构 心力衰竭 抑制 Myocardial remodeling Cardiac failure Inhibition
  • 相关文献

参考文献11

  • 1Udelson JE.Ventricular remodeling in heart failure and the effect of beta-blockade[J].Am J Cardio,2004,93(9A):43B-48B.
  • 2邢绣荣,华琦,方亮.氯沙坦对原发性高血压患者心脏结构和功能的影响[J].中国医学影像技术,2000,16(8):647-649. 被引量:4
  • 3王静,艾沙,高方明.雷米普利治疗原发性高血压左室重构的疗效观察[J].现代诊断与治疗,2002,13(1):48-48. 被引量:2
  • 4Patel R, Nagueh SF, Tsybouleva N, et al. Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertropnic cardiomyopathy[J].Circulation,2001,104(3):317-324.
  • 5Kaftan HA,Evrengul H,Tanriverdi H,et al.Effect of insulin resistance on left ventrieular structural changes in hypertensive patients[J]. Int Heart,2006, 47(3):391-400.
  • 6Rousseau MF,GurneO,Duprez D,et al.Beneficial neurohormonal profile of spironolactone in severe congestive heart failure:results from the RALES neurohormonal substudy[J]. J Am Coll Cardio,2002,40(9):1596-1601.
  • 7Lariviere R,Lelel M.Endothelin-1 in chronic renal failure and hypertension[J].Can J Pharmaco,2003,81(6):607-621.
  • 8Goddard J, Johnston NR, Hand MF,et al. Endothelin-A receptor antago- nism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure:a comparison of selective and corn bined endothelin receptor blockade[J].Circulation,2004,109(9):1186-1193.
  • 9汪涛,康毅,娄建石.激肽释放酶-激肽系统的心血管领域研究进展[J].中国药理学与毒理学杂志,2003,17(6):466-470. 被引量:27
  • 10Allan A, Fenning A,Levick S,et al.Reversal of cardiac dysfunction by selective ET-A receptor antagonism[J]. Br J Pharmaco,2005,146(6):846--853.

二级参考文献3

共引文献29

同被引文献18

  • 1Paulus WJ, TschSpe C, Sanderson JE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology [J].Eur Heart J, 2007, 28(20):2539-2550.
  • 2Steinberg BA, Zhao X, Heidenreich PA, et al.Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outeomes[J].Circulation, 2012,126(1):65-75. DOI: 10.1161/CIRCULATIONAHA. 111.080770.
  • 3Kitzman DW. Outcomes in patients with heart failure with preserved ejection fraction: it is more than the heart[J].J Am Coil Cardiol, 2012, 59(11):1006-1007. DOI: 10.1016/j.jacc.2011.12.011.
  • 4Borlaug BA, Lam CS, Roger VL, et al. Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction [J]. J Am Coil Cardiol, 2009, 54(5): 410-418. DOI: 10.1016/j.jaee.2009.05.013.
  • 5Cleland JG, Tendera M, Adamus J, et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study[J]. Eur Heart J, 2006, 27(19):2338-2345.
  • 6Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricnlar ejection fraction: the CHARM-Preserved Trial[J].Lancet, 2003, 362(9386):777-781.
  • 7Schillaci G, Pucci G, Pirro M. Irbesartan for heart failure with preserved ejection fraction[J].N Engl J Med, 2009, 360(12):1258.
  • 8Mc Murray JJ,Adamopoulos S,Anker SD,et al.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012:The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association(HFA)of the ESC[J].Eur Heart J,2012,33(14):1787.
  • 9STEINBERG B A,ZHAO X,HEIDENREICH P A,et al.Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction:prevalence,therapies,and outcomes[J].Circulation,2012,126(1):65.
  • 10KITZMAN D W.Outcomes in patients with heart failure with preserved ejection fraction:it is more than the heart[J].J Am Coll Cardiol,2012,59(11):1006.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部